Literature DB >> 10984006

Omega-3 fatty acids in psychiatry: a review.

M P Freeman1.   

Abstract

Omega-3 fatty acids are long-chain, polyunsaturated fatty acids found in plant and marine sources. Unlike saturated fats, which have been shown to have negative health consequences, omega-3 fatty acids are polyunsaturated fatty acids that have been associated with many health benefits. Omega-3 fatty acids may prove to be efficacious in a number of psychiatric disorders. Mood disorders have been associated with abnormalities in fatty acid composition. Several lines of evidence suggest that diminished omega-3 fatty acid concentrations are associated with mood disorders. Clinical data are not yet available regarding omega-3 fatty acids in the treatment of major depression. However, one double-blind treatment trial has been conducted in bipolar disorder. Also, substantial evidence does exist supporting a potential role of omega-3 fatty acids in schizophrenia, although treatment data are needed. A case has been reported in which a patient with schizophrenia was successfully treated with omega-3 fatty acids. Controlled studies are necessary to explore the potential treatment of schizophrenia with omega-3 fatty acids. Omega-3 fatty acids may also be helpful in the treatment of dementia. Furthermore, omega-3 fatty acids may prove to be a safe and efficacious treatment for psychiatric disorders in pregnancy and in breastfeeding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984006     DOI: 10.1023/a:1009069002816

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  26 in total

Review 1.  Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain.

Authors:  Artemis P Simopoulos
Journal:  Mol Neurobiol       Date:  2011-01-29       Impact factor: 5.590

2.  Differential effects of modulation of docosahexaenoic acid content during development in specific regions of rat brain.

Authors:  Beth Levant; Marlies K Ozias; Karra A Jones; Susan E Carlson
Journal:  Lipids       Date:  2006-05       Impact factor: 1.880

Review 3.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Nutrition and depression: implications for improving mental health among childbearing-aged women.

Authors:  Lisa M Bodnar; Katherine L Wisner
Journal:  Biol Psychiatry       Date:  2005-07-25       Impact factor: 13.382

5.  Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders.

Authors:  Helen Lavretsky
Journal:  Aging health       Date:  2009-02-01

Review 6.  Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen; Susan J van Rensburg
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis.

Authors:  Anna Liisa Suominen-Taipale; Timo Partonen; Anu W Turunen; Satu Männistö; Antti Jula; Pia K Verkasalo
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

Review 8.  Women and bipolar disorder across the life span.

Authors:  Dorothy Sit
Journal:  J Am Med Womens Assoc (1972)       Date:  2004

9.  Perils of Pragmatic Psychiatry: How We Can Do Better.

Authors:  Maju Mathew Koola; Joseph Sebastian
Journal:  HSOA J Psychiatry Depress Anxiety       Date:  2016-02-23

10.  Food consumption frequency and perceived stress and depressive symptoms among students in three European countries.

Authors:  Rafael T Mikolajczyk; Walid El Ansari; Annette E Maxwell
Journal:  Nutr J       Date:  2009-07-15       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.